Trial intelligence / Profile preview

Metformin add-on insulin in type 2 diabetes patients with cirrhosis

ChiCTR2000030133Phase 4Recruiting

Sponsor
Jingjiang People's Hospital
Start
Jan 2019
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of metformin and human insulin in type 2 diabetes mellitus (T2DM), sponsored by Jingjiang People's Hospital. Primary endpoints: MAGE, SD and 2 more. Started Jan 2019; status: recruiting.

02

Drugs

metforminhuman insulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on ChiCTR2000030133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call